| Test Name and Number |
Recommended Use |
Limitations |
Follow Up |
| Angiotensin Converting Enzyme, Serum 0080001 Method: Enzymatic |
Support diagnosis of sarcoidosis or neurosarcoidosis via ACE levels in serum
Evaluate response to treatment via ACE
|
Antihypertensive medications such as ACE inhibitors, ACE receptor blockers and diuretics may interfere with test results This test is not specific for diagnosis of sarcoidosis Test is a nonspecific indicator of response to treatment In neurosarcoidosis, serum ACE concentrations are less likely to be elevated than CSF ACE concentrations. CSF ACE levels are increased in about 55% of patients with neurosarcoidosis, 5% of those with sarcoidosis (without neurologic abnormality) and 13% of those with other neurological diseases |
Further tissue biopsy and evaluation for granulomas is necessary to confirm the diagnosis
|
| Angiotensin Converting Enzyme, CSF 0098974 Method: Spectrophotometry |
Support diagnosis of sarcoidosis or neurosarcoidosis via ACE levels in CSF
Evaluate response to treatment via ACE
|
Antihypertensive medications such as ACE inhibitors, ACE receptor blockers and diuretics may interfere with test results This test is not specific for sarcoidosis Test is a nonspecific indicator of response to treatment |
|
| Lymphocyte Subsets Panel 4 - T-Cell Subsets Percents & Ratio, Bronchoalveolar Lavage 0093420 Method: Flow Cytometry |
Assist in the diagnosis of sarcoidosis when biopsy is negative
|
|
|
| Calcium, Serum or Plasma 0020027 Method: Spectrophotometry |
Evaluate for presence of hypercalcemia |
|
|
| Calcium, Urine 0020472 Method: Spectrophotometry |
Evaluate for presence of hypercalcemia |
|
|
| Aspartate Aminotransferase, Serum or Plasma 0020007 Method: Enzymatic |
Evaluate for liver disease involvement |
|
|
| Alanine Aminotransferase, Serum or Plasma 0020008 Method: Enzymatic |
Evaluate for liver disease involvement |
|
|
| Alkaline Phosphatase, Serum or Plasma 0020005 Method: Enzymatic |
Evaluate for liver disease involvement |
|
|
| QuantiFERON®-TB Gold In Tube & Mycobacterium tuberculosis Antibody, IgG 2001627 Method: Cell Culture/Enzyme-Linked Immunosorbent Assay |
Rule out other granulomatous diseases |
|
|
| Hepatic Function Panel 0020416 Method: Refer to individual components. |
Evaluate for liver disease involvement |
|
|